Advisory—Mylan recalls Methotrexate Injection (USP 50mg/2mL) due to particulate matter
Mylan Pharmaceuticals ULC, in consultation with Health Canada, is voluntarily recalling one lot of Methotrexate Injection USP 50 mg/2 mL due to the potential presence of foreign particulate matter.